Activist 13D/13G Filings - BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-12
10:06 am
Sale
13GBRAINSTORM CELL THERAPEUTICS I
BCLI
Ness Kevin Dean3,060,000
6.25%
-600,000decrease
(-16.39%)
View
2023-04-05
10:47 am
Purchase
13GBRAINSTORM CELL THERAPEUTICS I
BCLI
Ness Kevin Dean3,660,000
9.98%
360,000increase
(+10.91%)
View
2022-02-14
4:05 pm
Purchase
13GBRAINSTORM CELL THERAPEUTICS I
BCLI
Abbhi Investments LLC2,425,853
6.69%
53,445increase
(+2.25%)
View
2022-02-04
4:08 pm
Purchase
13GBRAINSTORM CELL THERAPEUTICS I
BCLI
Ness Kevin Dean3,300,000
9.1%
3,300,000increase
(New Position)
View
2021-07-12
08:29 am
Sale
13GBRAINSTORM CELL THERAPEUTICS I
BCLI
BlackRock Inc.
BLK
474,347
1.3%
-1,445,993decrease
(-75.30%)
View
2021-02-02
3:13 pm
Purchase
13GBRAINSTORM CELL THERAPEUTICS I
BCLI
BlackRock Inc.
BLK
1,920,340
6.1%
1,920,340increase
(New Position)
View
2020-05-08
12:04 pm
Purchase
13DBRAINSTORM CELL THERAPEUTICS I
BCLI
Daly Joseph Patrick1,077,500
3.66%
42,319increase
(+4.09%)
View
2020-04-08
06:01 am
Purchase
13DBRAINSTORM CELL THERAPEUTICS I
BCLI
Abbhi Investments LLC2,372,408
9.04%
4,657increase
(+0.20%)
View
2020-03-17
9:30 pm
Purchase
13GBRAINSTORM CELL THERAPEUTICS I
BCLI
Abbhi Investments LLC2,367,751
9.03%
2,367,751increase
(New Position)
View
2019-11-21
07:15 am
Purchase
13DBRAINSTORM CELL THERAPEUTICS I
BCLI
Daly Joseph Patrick1,035,181
4.58%
1,035,181increase
(New Position)
View